Modulating mTOR in aging and health

Simon C Johnson, Maya Sangesland, Matt Kaeberlein, Peter S Rabinovitch

Research output: Contribution to journalReview articlepeer-review

68 Citations (Scopus)

Abstract

The physiological responses to nutrient availability play a central role in aging and disease. Genetic and pharmacological studies have identified highly conserved cellular signaling pathways that influence aging by regulating the interface between nutrient and hormone cues and cellular growth and maintenance. Among these pathways, the mechanistic target of rapamycin (mTOR) has been most reproducibly shown to modulate aging in evolutionarily diverse organisms as reduction in mTOR activity extends life span from yeast to rodents. mTOR has been shown to play a role in a broad range of diseases, and is of particular interest to human health and aging due to the availability of clinically approved pharmacological agents targeting the mTOR complexes and other components of the mTOR signaling network. Characterizing the role of mTOR in aging and health promises to provide new avenues for intervention in human aging and disease through modulation of this signaling pathway.

Original languageEnglish
Pages (from-to)107-27
Number of pages21
JournalInterdisciplinary Topics in Gerontology
Volume40
DOIs
Publication statusPublished - 2015
Externally publishedYes

Fingerprint

Dive into the research topics of 'Modulating mTOR in aging and health'. Together they form a unique fingerprint.

Cite this